vs
Side-by-side financial comparison of Adagene Inc. (ADAG) and TAKEDA PHARMACEUTICAL CO LTD (TAK). Click either name above to swap in a different company.
Adagene Inc. is a global clinical-stage biotechnology company specializing in the research, development, and commercialization of innovative antibody-based cancer immunotherapies. Leveraging its proprietary next-generation antibody technology platforms, it develops targeted oncology treatments for patients across global markets, with core R&D bases in China and clinical programs covering North America, Asia, and Europe.
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived th...
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 25 | — | $4.3M | ||
| Q1 24 | — | $4.0M |
| Q2 25 | — | $144.2K | ||
| Q1 24 | — | $317.0K |
| Q2 25 | — | 66.5% | ||
| Q1 24 | — | 69.1% |
| Q2 25 | — | 5.0% | ||
| Q1 24 | — | 12.2% |
| Q2 25 | — | 3.4% | ||
| Q1 24 | — | 7.9% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
